01 1Shandong Anhong Pharmaceutical
01 1ENZALUTAMIDE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-09-21
Pay. Date : 2023-07-19
DMF Number : 38592
Submission : 2023-08-11
Status : Active
Type : II
20
Shandong Anhong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ENZALUTAMIDE, with a corresponding US DMF Number 38592.
Remarkably, this DMF maintains an Active status since its submission on August 11, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2023, and payment made on July 19, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
